RA CAPITAL MANAGEMENT L.P. 13D and 13G filings for Connect Biopharma Holdings Limited:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-27 4:19 pm Sale | 2024-02-23 | 13D | Connect Biopharma Holdings Limited CNTB | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -3,062,871 (Position Closed) | Filing |
| 2023-12-20 4:30 pm Sale | 2023-12-18 | 13D | Connect Biopharma Holdings Limited CNTB | RA CAPITAL MANAGEMENT L.P. | 3,062,871 5.600% | -2,061,438 (-40.23%) | Filing |
| 2023-12-14 4:30 pm Sale | 2023-12-12 | 13D | Connect Biopharma Holdings Limited CNTB | RA CAPITAL MANAGEMENT L.P. | 5,124,309 9.300% | -830,702 (-13.95%) | Filing |
| 2023-12-04 5:20 pm Sale | 2023-11-30 | 13D | Connect Biopharma Holdings Limited CNTB | RA CAPITAL MANAGEMENT L.P. | 5,955,011 10.800% | -1,035,992 (-14.82%) | Filing |
| 2021-06-07 5:12 pm Purchase | 2021-06-04 | 13D | Connect Biopharma Holdings Limited CNTB | RA CAPITAL MANAGEMENT L.P. | 6,991,003 12.200% | 350,586 (+5.28%) | Filing |
| 2021-03-29 4:30 pm Purchase | 2021-03-19 | 13D | Connect Biopharma Holdings Limited CNTB | RA CAPITAL MANAGEMENT L.P. | 6,640,417 11.500% | 6,640,417 (New Position) | Filing |